Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis

The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mult Scler
Glavni autori: Motl, Robert W, Cohen, Jeffrey A, Benedict, Ralph, Phillips, Glenn, LaRocca, Nicholas, Hudson, Lynn D, Rudick, Richard
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2017
Teme:
Invited Reviews
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5405807/
https://ncbi.nlm.nih.gov/pubmed/28206828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517690823
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items